Prognostic value of the estrogen receptor level in pathologic stage I and II adenocarcinoma of the breast
- 1 February 1982
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 19 (2) , 119-121
- https://doi.org/10.1002/jso.2930190216
Abstract
The relationship between estrogen receptor levels and recurrence of breast cancer was examined in 302 patients with adenocarcinoma of the breast, pathologic stage (PS) I and II. All 117 patients with PS II adenocarcinoma of the breast received adjunctive chemotherapy. In this series, there was no association between the estrogen receptor level and recurrence in either the 185 patients with PS I adenocarcinoma of the breast or the 117 patients with PS II adenocarcinoma of the breast. The most important prognostic variable was the presence or absence of axillary metastases.Keywords
This publication has 6 references indexed in Scilit:
- The relative importance of estrogen receptor analysis as a prognostic factor for recurrence or response to chemotherapy in women with breast cancerCancer, 1980
- ASSOCIATION BETWEEN STEROID-HORMONE RECEPTOR STATUS AND DISEASE-FREE INTERVAL IN BREAST-CANCER1979
- Estrogen Receptors and Responses to Chemotherapy and Hormonal Therapy in Advanced Breast CancerNew England Journal of Medicine, 1978
- The Relation between Estrogen Receptors and Response Rate to Cytotoxic Chemotherapy in Metastatic Breast CancerNew England Journal of Medicine, 1978
- Low incidence of estrogen receptor in breast carcinomas with rapid rates of cellular replicationCancer, 1977
- SURGICAL IMPLICATIONS OF ESTROPHILE PROTEIN ESTIMATIONS IN CARCINOMA OF BREAST1976